This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Asian Healthcare Specialists Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

Wichtige Informationen

28.2%

Wachstumsrate der Gewinne

10.1%

EPS-Wachstumsrate

Healthcare Wachstum der Industrie	9.7%
Wachstumsrate der Einnahmen	26.0%
Eigenkapitalrendite	10.8%
Netto-Marge	19.0%
Letzte Ertragsaktualisierung	31 Mar 2022

Jüngste Aktualisierungen vergangener Leistungen

Recent updates

Aufschlüsselung der Einnahmen und Ausgaben

Wie Asian Healthcare Specialists Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.

Gewinn- und Umsatzhistorie

Catalist:1J3 Einnahmen, Ausgaben und Erträge (SGD Millions)
Datum	Einnahmen	Umsatz
31 Mar 22	28	5
31 Dec 21	28	5
30 Sep 21	28	4
30 Jun 21	25	4
31 Mar 21	23	4
31 Dec 20	20	3
30 Sep 20	17	3
30 Jun 20	15	3
31 Mar 20	13	3
31 Dec 19	13	3
30 Sep 19	12	3
30 Jun 19	12	3
31 Mar 19	11	2
31 Dec 18	11	2
30 Sep 18	11	2
30 Jun 18	11	2
31 Mar 18	11	2
31 Dec 17	11	1
30 Sep 17	11	0
30 Sep 16	11	2

Qualität der Erträge: 1J3 has high quality earnings.

Wachsende Gewinnspanne: 1J3's current net profit margins (19%) are higher than last year (15.4%).

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Ergebnisentwicklung: 1J3's earnings have grown significantly by 28.2% per year over the past 5 years.

Beschleunigtes Wachstum: 1J3's earnings growth over the past year (47.9%) exceeds its 5-year average (28.2% per year).

Erträge im Vergleich zur Industrie: 1J3 earnings growth over the past year (47.9%) exceeded the Healthcare industry 17.8%.

This company listing is no longer active

Asian Healthcare Specialists Vergangene Ertragsentwicklung

Vergangenheit Kriterienprüfungen 5/6

Wichtige Informationen

Jüngste Aktualisierungen vergangener Leistungen

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2020 earnings released: EPS S$0.007

Recent updates

Doctor Anywhere Pte Ltd completed the acquisition of Asian Healthcare Specialists Limited (Catalist:1J3) from from group of sellers.

Doctor Anywhere Pte Ltd intends to make a voluntary cash offer to acquire Asian Healthcare Specialists Limited (Catalist:1J3) from group of sellers for approximately SGD 110 million.

Asian Healthcare Specialists Limited Approves Final Tax-Exempt Dividend for the Financial Year Ended 30 September 2021, Payable on 16 February 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Asian Healthcare Specialists Limited Declares Interim Dividend (One-Tier Tax Exempt) in Respect of the Financial Period Ended 31 March 2021, Payable on or About 1 June, 2021

New 90-day high: S$0.21

Full year 2020 earnings released: EPS S$0.007

Asian Healthcare Specialists Limited, Annual General Meeting, Jan 28, 2021

New 90-day high: S$0.20

Asian Healthcare Specialists Limited announced that it has received SGD 3 million in funding from Encyclia 1 Investments Pte. Ltd.

Asian Healthcare Specialists Limited announced that it expects to receive SGD 3 million in funding from Encyclia Investments

New 90-day high - S$0.24

Aufschlüsselung der Einnahmen und Ausgaben

Gewinn- und Umsatzhistorie

Analyse von freiem Cashflow und Gewinn

Analyse des Gewinnwachstums in der Vergangenheit

Eigenkapitalrendite

Kapitalrendite

Rendite auf das eingesetzte Kapital

Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren